Technical Analysis for PLX - Protalix BioTherapeutics, Inc.

Grade Last Price % Change Price Change
grade B 0.4799 -4.02% -0.02
PLX closed down 4.02 percent on Wednesday, March 20, 2019, on 1.67 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical PLX trend table...

Date Alert Name Type % Chg
Mar 20 200 DMA Support Bullish 0.00%
Mar 20 Upper Bollinger Band Touch Strength 0.00%
Mar 19 MACD Bullish Signal Line Cross Bullish -4.02%
Mar 19 Upper Bollinger Band Touch Strength -4.02%
Mar 18 200 DMA Support Bullish -0.66%
Mar 18 20 DMA Support Bullish -0.66%
Mar 18 Inside Day Range Contraction -0.66%
Mar 15 Crossed Above 200 DMA Bullish -2.26%
Mar 15 Crossed Above 20 DMA Bullish -2.26%
Mar 15 Crossed Above 50 DMA Bullish -2.26%

Older signals for PLX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system. It offers taliglucerase alfa for injection, which is marketed under the ELELYSO brand name, as an enzyme replacement therapy for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease. The company's product pipeline includes PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications; and an orally-administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant enzyme produced within carrot cells. Its product pipeline also comprises PRX-106 or pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor and an antibody portion, which is being developed as a treatment of certain immune diseases, such as rheumatoid arthritis, Chrohn's disease, placque psoriasis, and other autoimmune disorders; and two additional undisclosed therapeutic proteins that are being evaluated in animal studies. It has a collaboration and licensing agreement with Teva Pharmaceutical Industries Ltd. to develop and manufacture two proteins using its ProCellEx protein expression system. The company was founded in 1993 and is based in Carmiel, Israel.
Biotechnology Biopharmaceutical Life Sciences Biology Rheumatoid Arthritis Autoimmune Disorders Enzyme Replacement Therapy Fabry Disease Gaucher Disease Treatment Of Fabry Disease Recombinant Dna
Is PLX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.83
52 Week Low 0.27
Average Volume 691,636
200-Day Moving Average 0.4754
50-Day Moving Average 0.4586
20-Day Moving Average 0.4733
10-Day Moving Average 0.4706
Average True Range 0.0411
ADX 18.41
+DI 19.0045
-DI 14.7233
Chandelier Exit (Long, 3 ATRs ) 0.4267
Chandelier Exit (Short, 3 ATRs ) 0.5534
Upper Bollinger Band 0.5062
Lower Bollinger Band 0.4404
Percent B (%b) 0.6
BandWidth 13.902388
MACD Line 0.006
MACD Signal Line 0.005
MACD Histogram 0.0009
Fundamentals Value
Market Cap 64 Million
Num Shares 133 Million
EPS -0.60
Price-to-Earnings (P/E) Ratio -0.80
Price-to-Sales 6.07
Price-to-Book 0.00
PEG Ratio -0.16
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.53
Resistance 3 (R3) 0.53 0.52 0.52
Resistance 2 (R2) 0.52 0.51 0.52 0.52
Resistance 1 (R1) 0.50 0.50 0.49 0.50 0.52
Pivot Point 0.49 0.49 0.48 0.49 0.49
Support 1 (S1) 0.47 0.47 0.46 0.46 0.44
Support 2 (S2) 0.45 0.47 0.45 0.44
Support 3 (S3) 0.43 0.45 0.44
Support 4 (S4) 0.43